eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse all drugs       All conditions, symptoms, side effects

From FDA reports: drug interactions between Gilenya, Oxybutynin for a Male patient aged 28

This is a personalized study for a 28 year old male patient. The study is created by eHealthMe based on reports of 166 people who take the same drugs and have drug interactionsfrom FDA.

Get a free personalized report of your drugs: we study for you 353 million drug outcomes from FDA and social media. Start to use eHealthMe >>>

On Jul, 25, 2014: 166 people who reported to have interactions when taking Gilenya, Oxybutynin are studied

Trend of Gilenya, Oxybutynin's drug interactions, side effects, and effectiveness reports (8890076)

Information of the patient in this study:

Age: 28

Gender: male

Conditions: Relapsing-remitting Multiple Sclerosis, Bladder Dysfunction

Drugs taking:
- Gilenya: used for 1 - 6 months
- Oxybutynin

Drug interactions have: Perivascular Dermatitis, Skin Lesion, Cd4 Lymphocytes Decreased

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 28 (±5):

InteractionNumber of reports
Perivascular Dermatitis (inflammation of the skin)2 (50.00%)
Skin Lesion (redness)3 (75.00%)
Cd4 Lymphocytes Decreased4 (100.00%)

Most common interactions experienced by males aged 28 (±5) in the use of Gilenya, Oxybutynin:

InteractionNumber of reports
Blood Pressure Decreased (abnormally low blood pressure)4
Hypokalaemia (low potassium)4
Fatigue (feeling of tiredness)4
Heart Rate Increased4
Haematocrit Decreased4
Tremor (trembling or shaking movements in one or more parts of your body)4
Malaise (a feeling of general discomfort or uneasiness)4
Balance Disorder4
Urinary Incontinence (inability to control the flow of urine and involuntary urination)4
Headache (pain in head)4

Most common interactions experienced by males aged 28 (±5) in long term use of Gilenya, Oxybutynin:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Perivascular Dermatitis (inflammation of the skin)2 (1.20%)
Skin Lesion (redness)20 (12.05%)
Cd4 Lymphocytes Decreased6 (3.61%)

Most common interactions experienced by people in the use of Gilenya, Oxybutynin:

InteractionNumber of reports
Asthenia (weakness)102
Fatigue (feeling of tiredness)75
Dizziness55
Chest Pain53
Headache (pain in head)48
Gait Disturbance48
White Blood Cell Count Decreased48
Hypoaesthesia (reduced sense of touch or sensation)44
Heart Rate Decreased38
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)38

Most common interactions experienced by people in long term use of Gilenya, Oxybutynin:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.